English
Polski
Español
українська
Management in patients with rheumatic diseases treated with biologics prior to a travel to the tropics
How to manage a patient with a rheumatic disease on biologic drugs prior to a travel to the tropics? With Dr Somia Iqtadar.
2024-05-11
How to manage a patient with a rheumatic disease on biologic drugs prior to a travel to the tropics? With Dr Somia Iqtadar.
How to manage a patient with fever during or after a travel to the tropics? With Dr Somia Iqtadar.
What are the most pressing infectious disease risks for individuals traveling to tropical countries, both among diseases preventable by vaccination and other conditions? With Dr Somia Iqtadar.
What are the key principles of vaccination in immunosuppressed individuals planning a trip to the tropics? With Dr Somia Iqtadar.
What type of pain is most prevalent in long COVID and how to manage it?
Have there been any breakthrough reports or any new important guidelines in the field of infectious diseases?
Is it already known which are better in providing medical care to those infected with SARS-CoV-2: medical masks or N95 respirators? Should we recommend the use of N95 respirators by immunosuppressed patients in the setting of increased exposure to pathogens transmitted by inhalation, including SARS-CoV-2?
Following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, many people develop long COVID with various clinical manifestations. What is known about the etiology and pathogenesis of long COVID? Is the mechanism similar, to, for example, chronic fatigue syndrome after other infections? Is it possible to shorten the duration of long COVID symptoms?
Should patients with neutropenia be screened for aspergillosis, eg, with periodic galactomannan testing? Is a positive galactomannan test result without abnormal radiologic findings an indication to initiate treatment in a patient with neutropenia?
When to include a fungal infection in the differential diagnosis in an immunosuppressed patient?
